Literature DB >> 9629553

[Tau protein. A potential biological indicator for early detection of Alzheimer disease].

K Buch1, M Riemenschneider, P Bartenstein, F Willoch, U Müller, M Schmolke, T Nolde, C Steinmann, W G Guder, A Kurz.   

Abstract

In 40 patients with Alzheimer's disease (AD), in 5 patients with non-AD dementia and in 36 cognitively normal controls the concentration of protein tau was determined in the cerebrospinal fluid (CSF). Of the AD patients, 19 were very mildly demented (MMSE score from 25 to 28). Even in these patients, CSF tau was significantly more elevated than in controls. In the non-AD patients protein tau was less increased. Among the AD patients there was no association between CSF tau and severity of cognitive impairment or deficit in cerebral blood flow, determined by SPECT. Our findings suggest that CSF tau may be elevated even at the predementia stage of AD and be useful as a biological marker for the early recognition of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629553     DOI: 10.1007/s001150050286

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

1.  [Alzheimer dementia: positive diagnosis and prevention].

Authors:  Johannes Kornhuber
Journal:  Nervenarzt       Date:  2002-05       Impact factor: 1.214

Review 2.  Transcellular Spreading of Tau in Tauopathies.

Authors:  Koen Demaegd; Joost Schymkowitz; Frederic Rousseau
Journal:  Chembiochem       Date:  2018-10-12       Impact factor: 3.164

Review 3.  Protein transmission in neurodegenerative disease.

Authors:  Chao Peng; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Rev Neurol       Date:  2020-03-23       Impact factor: 44.711

Review 4.  Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.

Authors:  Hadeel Alyenbaawi; W Ted Allison; Sue-Ann Mok
Journal:  Biomolecules       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.